Bullous pemphigoid and milia: prevalence and clinical laboratory findings in a Brazilian sample

An Bras Dermatol. 2022 Jul-Aug;97(4):435-442. doi: 10.1016/j.abd.2021.10.003. Epub 2022 May 27.

Abstract

Background: Bullous pemphigoid (BP) associated with milia lesions has been increasingly reported, but its prevalence has not been reported in a Brazilian BP population yet.

Objectives: To describe the occurrence and clinical-laboratorial findings of BP-milia association in a southeastern Brazilian sample.

Methods: A descriptive study based on the medical charts of 102 BP patients was accomplished. Clinical and laboratory data of BP-milia patients were compiled. Total serum IgE measurements, immunoblot assays based on basement membrane zone antigens, and HLA-DQ alleles typing were performed.

Results: Milia was evident in 8 (7.8%) BP patients, five males, aged between 46 and 88 years. Increased total IgE levels were determined in 7 (87.5%) of the eight patients. In five of eight patients, immunoblotting showed IgG reactivity against the BP180-NC16a domain but not against collagen VII or laminin-332; it also revealed reactivity against the BP180 C-terminal domain or LAD-1, or both in four of them. The HLA-DQB1*03:01 and HLA-DQA1*05:05 alleles were identified in three of five BP-milia patients. Moreover, three of five cases presented the HLA-DQB1*06 allelic group.

Study limitations: HLA determination was performed in five patients.

Conclusions: Milia formation in BP patients seems to be less uncommon than previously admitted. Laboratory data revealed increased IgE; autoantibodies against the BP180 C-terminal domain or LAD-1, or both; and the HLA-DQB1*06 allelic group, described for the BP-milia association. Careful determination of antibodies against basement membrane zone molecules and HLA characterization in different populations may provide further insights into this association.

Keywords: 230 kDa protein; HLA antigens; Hemidesmosomal plaque protein; Pemphigoid, bullous.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Autoantibodies
  • Autoantigens
  • Brazil
  • Humans
  • Immunoglobulin E
  • Keratosis* / pathology
  • Laboratories, Clinical
  • Male
  • Middle Aged
  • Non-Fibrillar Collagens
  • Pemphigoid, Bullous* / pathology
  • Prevalence

Substances

  • Autoantibodies
  • Autoantigens
  • Non-Fibrillar Collagens
  • Immunoglobulin E